Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous bone marrow mesenchymal stem cells (Jie Shen)
- Development stage
- Unknown
- Lead developer
- The Third Affiliated Hospital of Southern Medical University
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intramuscular, Intra-arterial
01
Overview
Autologous bone marrow mesenchymal stem cells (BM-MSCs) are an investigational cell therapy being evaluated by investigator Jie Shen for the treatment of diabetic foot and peripheral vascular disease. The therapeutic process involves the extraction of stem cells from the patient's own bone marrow, followed by processing and reinjection into the affected limb. These cells are hypothesized to address diabetes-related vascular complications by promoting angiogenesis (the formation of new blood vessels) and providing immunomodulatory effects. By secreting various paracrine factors, such as vascular endothelial growth factor (VEGF) and other cytokines, the cells help restore blood flow to ischemic tissues and facilitate the healing of chronic diabetic ulcers.
- Other names
- autologous bone marrow stem cellsBM-MSCsmesenchymal stem cells
Beyond the preview
Go deeper on autologous bone marrow mesenchymal stem cells (Jie Shen).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous bone marrow mesenchymal stem cells (Jie Shen).